Hope Lodges provides free, home-like accommodations for cancer patients who have to travel for treatment. ProposalCentral for Institutions | Altum : Altum 8 ways the American Cancer Society has impacted the future of cancer 1. Membership Benefits . The American Cancer Society is proud to offer help and resources no matter where you live. Link to ProposalCentral: https://proposalcentral.altum.com/default.asp. Background for the interdisciplinary research plan. Cancer stem cells could be the Achilles heelfor effective frontline oncology treatments. Some of the topics we can assist with include: For medical questions, we encourage you to review our information with your doctor. At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. Overview: The selected research team includes interdisciplinary members to promote transformational advances in cancer stem cell research. Tips from how to select a grant to when to expect award announcements. American Cancer Society - Wikipedia Some of the topics we can assist with include: For medical questions, we encourage you to review our information with your doctor. The award may be for three to five years with $135,000 a year for direct costs, plus 8% allowable indirect costs. Description of the interdisciplinary team and how this team is well positioned to successfully achieve the goals of the project and contribute to the cancer stem cell field. Tax ID Number: 13-1788491. All proposals should be hypothesis-driven with a focus on cancer stem cells and include an articulated vision for reducing the burdens of cancer. There are significant knowledge gaps about how cancer stem cells can be so persistent in a variety of cancer types. Cancer in North America CiNA Data Products - NAACCR Select theLiveChat button at the bottom of the page. Any applicant who self-identifies as a member of any of the Underrepresented Populations in the U.S. Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise as listed in the Notice of NIH's Interest in Diversity(NOT-OD-20-031). This is a joint effort with the American Association of Physicists in Medicine (AAPM) to support the research of medical physics residents and postdoctoral fellows, and advance their careers. See Cancer Stem Cell Consortium Instructions PDFand Cancer Stem Cell Consortium Policies PDF. Application Deadlines: April 1*and Oct. 15*. The American Cancer Society is the largest, not-for-profit funding source for cancer research in the United States. ACS Research and Clinical Research Professors. . Funding Opportunities - American Society for Radiation Oncology - ASTRO September 18, 2020 , by NCI Staff Widely used guidelines on screening women for cervical cancer have several important changes, including a recommendation to start screening at a slightly older age and use of an HPV test as the primary screening test. The biology-focused seed grant supports trainees advancing biological research in radiation oncology and/or cancer focused sciences. The ACS Research Professor and Clinical Research Professor Awards are the most prestigious grants made by our national program. Application Deadline: February 10, 2023; 11:59 p.m. Eastern time. This intellectual freedom to pursue the most promising course of research has yielded proposals from gifted, innovative investigators in medical schools, universities, research institutes, and hospitals throughout the country, proposals for research that can be undertaken employing available knowledge and techniques. U.S. Eastern Time. HHS Vulnerability Disclosure, Help Look for funding opportunities you qualify for. Or ask us how you can get involved and support the fight against cancer. 4).Additional cancer incidence data for trends come from the Cancer Incidence in Five Continents (CI5) database of the International Association of . Background: Large-scale, prospective cohort studies have played a critical role in discovering factors that contribute to variability in cancer risk in human populations. The bill passed the House . We connect patients, caregivers, and family members with valuable services and resources. Our 24/7 cancer helpline provides support for people dealing with cancer. Abstract In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a complete update of recommendations for early prostate cancer detection. Are you a Grant Funder looking to increase visibility to potential applicants? Funding:3 to 5 years with $135K direct costs a year, plus 8% allowable indirect costs. Tax ID Number: 13-1788491. The American Cancer Society (ACS) and Lisa Dean Moseley Foundation are collaborating to create a research consortium that will advance the translation of cancer stem cell discoveries to accelerate the impact on patients. See if you're eligible for a clinical trial. Early career radiation oncologists, radiation or cancer biologists, or physicists are encouraged to submit radiation oncology research proposals that include at least 50% effort on melanoma. The American Cancer Society is a qualified 501(c)(3) tax-exempt organization. search . Click on the Proposals tab and then the default ALL status in the Proposal Status drop-down menu. AHA ProposalCentral - Professional Heart Daily | American Heart Association The LOI should be a maximum of 2 pages that describes: Invitation to Apply Date: By April 1, 2022, invitation-to-apply decisions will be communicated to applicants via proposalCENTRAL. All applications are submitted and reviewed throughProposalCentral. Expert Predictions: Cancer Care 10 Years from Now, Nobel Laureates and the American Cancer Society, How Epigenetics Could Improve Your Cancer Treatment, American Cancer Society Awards Medal of Honor for Extraordinary Contributions for Saving Lives from Cancer, Seven Breast Cancer Research Success Stories, A New Intervention for Improving Health After Cancer, ACS Mini Symposium May 2022: Translation of Cancer Research to Human Testing, Future Defenses Against Colorectal Cancer May Include a Vaccine and Genetic Engineering, Press Release: American Cancer Society Awards Research Professorships, Researchers Look for Ways to Improve Communication Between Cancer Patients and Doctors, Patient Navigators Can Help When Life Disrupts Cancer Care, A World Leader in Infection-Related Cancer Research: ACS Professor Profile, HPV Vaccine: A Powerful Way to Help Prevent 3+ Cancers in Women, "Cancer is basically a non-healing wound and we should treat it as such", Improving Precision Therapies for Non-Small Cell Lung Cancer, ACS Research Professor Recognized for Outstanding Achievement in Breast Cancer Research, American Cancer Society Research Professor Makes Strides Against Breast Cancer, American Cancer Society Funded Researchers Win Lasker Award, Class, Race, and Cancer: Unraveling the Complex Connections, Matthew Meyerson (Mentor) and Alison Taylor (Mentee), Personlized Cancer Care: Where It Stands Today, A Pioneer for Developing Drugs for People with T-Cell Lymphoma, Childhood Cancer Research Challenges and Opportunities: A Roundtable Discussion, Changing the Shape of Leukemia Research and Clinical Care, Improving Quality of Life for Lung Cancer Survivors, Referrals to patient-related programs or resources, Donations, website, or event-related assistance. Or ask us how you can get involved and support the fight against cancer. The American Cancer Society is a qualified 501(c)(3) tax-exempt organization. Making Strides Against Breast Cancer Walks, Volunteer Opportunities for Organizations, Making Strides Against Breast Cancer Walk, Featured: Making Strides Against Breast Cancer, Center for Diversity in Cancer Research (DICR) Training. Tax ID Number: 13-1788491. {currentyear} American Cancer Society, Inc. All rights reserved. ASTRO-AAPM Physics Residents/Postdoctoral Fellows Seed Grant Our 24/7 cancer helpline provides support for people dealing with cancer. ACS is dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer, through research, education, advocacy, and service. Research grants support scientists working in the following areas: The following is a listing of all available American Cancer Society research and training grants, including deadlines for submission of applications. Anderson Cancer Center in Houston Grant Term: 7/1/1996 through 3/31/2001 Area of Research: Chemoprevention Research of Aerodigestive Cancers Last Institution: University of Texas MD Anderson Cancer Center in Houston, Grant Institution: Salk Institute for Biological Studies in La Jolla, CA Grant Term: 1/1/1993 through12/31/2008 Area of Research: Protein phosphorylation in growth and oncogenesis Current Institution: Salk Institute of Biological Studies in La Jolla, CA, Grant Institution: Memorial Sloan-Kettering Cancer Center in New York City, NY Grant Term: 7/1/1989 through 12/31/1998 Area of Research: Molecular Biology Last Institution: Memorial Sloan-Kettering Cancer Center in New York City, NY, Grant Institution: Temple University of The Commonwealth System of Higher Education in Philadelphia, PA Grant Term: 7/1/2007 through 6/30/2018 Area of Research: Molecular Biology Current Institution: Fels Institute for Cancer Research & Molecular Biology in Philadelphia, PA, Grant Institution: Dana-Farber Cancer Institute in Boston, MA Grant Term: 7/1/2017 through 6/30/2022 Area of Research: Developing Precision Therapies for Lung Cancer Current Institution: Dana-Farber Cancer Institute in Boston, MA Lung Cancer Dream Team Makes Progress Improving Precision Therapies for Non-Small Cell Lung Cancer, Grant Institution: University of Chicago in Illinois Grant Term: 7/1/1963 through 3/31/1991 Area of Research: Molecular Biology Last Institution: University of Cincinnati in Ohio, Grant Institution: UMDNJ - Robert Wood Johnson Medical School New Brunswick, NJ Grant Term: 7/1/1994 through 6/30/2006 Area of Research: Folate Homeostasis and Cancer Chemotherapy Last Institution: Cancer Institute of New Jersey in New Brunswick, NJ, Grant Institution: Princeton University in Princeton, NJ Grant Term: 1/1/2020 through 12/31/2024 Area of Research: Stromal Niche as Regulators of Breast Cancer Metastasis Current Institution: Princeton University in Princeton, NJ ACS Research Professor Recognized for Outstanding Achievement in Breast Cancer Research American Cancer Society Research Professor Makes Strides Against Breast Cancer, Grant Institution: The Regents of the University of California, San Diego Grant Term: 1/1/1999 through 12/31/2008 Area of Research: Molecular Biology Current Institution: University of California, San Diego, Grant Institution: Cedars-Sinai Medical Center in Los Angeles, CA Grant Term: 7/1/2006 through 6/30/2016 Area of Research: Identification of Biomarkers for Ovarian Cancer Early Detection and Prognosis Current Institution: Cedars-Sinai Medical Center in Los Angeles, CA, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 1/1/2005 through 12/31/2014 Area of Research: Biochemistry and Biophysics Current Institution: University of California, San Francisco, Grant Institution: University of Washington School of Medicine in Seattle Grant Term: 7/1/1994 through 12/31/2024 Area of Research: Breast Cancer Current Institution: University of Washington School of Medicine in Seattle Seven Breast Cancer Research Success Stories American Cancer Society Funded Researchers Win Lasker Award, Grant Institution: Harvard University in Cambridge, MA Grant Term: 9/1/1963 through 8/31/1971 Area of Research: Molecular Biology Last Institution: Northwestern University Medical School in Chicago, IL, Grant Institution: Harvard University School of Public Health in Cambridge, MA Grant Term: 7/1/2015 through 8/31/2025 Area of Research: Social Epidemiology Current Institution: Harvard University in Cambridge, MA Class, Race, and Cancer: Unraveling the Complex Connections Press Release: American Cancer Society Awards Research Professorships, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 1/1/2003 through 12/31/2009 Area of Research: Immunology and Immuno-Oncology Current Institution: University of California San Francisco Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: The Regents of the University of Minnesota - Twin Cities Grant Term: 1/1/2013 through 12/31/2017 Area of Research: Functional Genomics of Cancer Progression Current Institution: University of Minnesota Twin Cities, Grant Institution: Health Research Inc. Roswell Park Cancer Institute Grant Term: 9/1/1960 through 12/31/1975 Area of Research: Biochemistry Current Institution: Saba University School of Medicine in the Dutch Caribbean, Grant Institution: Health Research Inc. Roswell Park Cancer Institute in Buffalo, NY Grant Term: 9/1/1959 through 8/31/1970 Area of Research: Molecular Biology Last Institution: Health Research Inc. Roswell Park Cancer Institute in Buffalo, NY, Grant Institution: Brandeis University in Waltham, MA Grant Term: 7/1/1962 through 8/31/1989 Area of Research: Molecular Biology Last Institution: Brandeis University in Waltham, MA, Grant Institution: Stanford University in California Grant Term: 7/1/1987 through 12/31/2011 Area of Research: Immunology and Immuno-Oncology Current Institution: Stanford University in California, Grant Institution: Dana-Farber Cancer Institute in Boston, MA Grant Term: 7/1/1998 through 6/30/2008 Area of Research: Cancer Control through Genetics Last Institution: Dana-Farber Cancer Institute in Boston, MA, Grant Institution: Albert Einstein College of Medicine, Yeshiva University in Bronx, NY Grant Term: 1/1/1994 through 12/31/1995 Area of Research: Molecular Biology Last Institution: Albert Einstein College of Medicine in Bronx, NY, Grant Institution: Tulane University in New Orleans, LA Grant Term: 7/1/1964 through 6/30/1972 Area of Research: Experimental Pathology and Molecular Biology Last Institution: Tulane University in New Orleans, LA, Grant Institution: University of Minnesota-- Twin Cities Grant Term: 7/1/1960 through 6/30/1982 Area of Research: Molecular Biology Last Institution: The Regents of the University of Minnesota Twin Cities, Grant Institution: Arizona Board of Regents, University of Arizona in Tucson Grant Term: 1/1/2006 through 12/31/2011 Area of Research: Development of A Program to Increase Colorectal Cancer Screening in Arizona Current Institution: University of California, San Diego, Grant Institution: University of Texas Health Science Center, San Antonio Grant Term: 7/1/1989 through 6/30/1994 Area of Research: Endocrinological Aspects of Breast Cancer Last Institution: National Institutes of Health in Bethesda, MD, Grant Institution: University of Colorado, Boulder Grant Term: 1/1/1994 through 6/30/2005 Area of Research: Analysis of Mitotic Mechanism Current Institution: University of Colorado, Boulder, Grant Institution: Johns Hopkins University in Baltimore, MD Grant Term: 7/1/2013 through 6/30/2018 Area of Research: Diagnosis and Risk Assessment in Barretts Esophagus Current Institution: Johns Hopkins University in Baltimore, MD, Grant Institution: Dana-Farber Cancer Institute in Boston, MA Grant Term: 1/1/2015 through 12/31/2024 Area of Research: Genome-inspired Approaches to Cancer Discovery and Therapeutics Current Institution: Dana-Farber Cancer Institute in Boston, MA Podcast: Matthew Meyerson (Mentor) and Alison Taylor (Mentee) Personlized Cancer Care: Where It Stands Today, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 7/1/2010 through 6/30/2020 Area of Research:Patient Care and Survivorship Issues Current Institution: University of California, San Francisco, Grant Institution: University of Pittsburgh in Philadelphia Grant Term: 1/1/2009 through 12/31/2018 Area of Research: Discovery and Characterization of Novel Human Tumor Viruses Current Institution: University of Pittsburgh Cancer Institute in Philadelphia, Grant Institution: Hahnemann University in Philadelphia, PA Grant Term: 1/1/1972 through 6/30/1978 Area of Research: Molecular Biology Current Institution: Hahnemann University in Philadelphia, PA, Grant Institution: Icahn School of Medicine at Mount Sinai in New York City, NY Grant Term: 7/1/2014 through 6/30/2024 Area of Research: Enhancing Quality of Life in Cancer Care Current Institution: Icahn School of Medicine at Mount Sinai in New York City, NY, Grant Institution: Northwestern University, Evanston Campus Grant Term: 12/1/1966 through 1/30/1992 Area of Research: Molecular Biology Current Institution: Northwestern University, Evanston Campus, Grant Institution: Columbia University in New York City Grant Term:7/1/2018 through 6/30/2023 Area of Research:Leukemia, Immunology, and Blood Cell Development Current Institution: Columbia University in New York City A Pioneer for Developing Drugs for People with T-Cell Lymphoma, Grant Institution: University of Chicago in Illinois Grant Term: 7/1/2010 through 6/30/2020 Area of Research: Toward a Primary Prevention of Breast Cancer in the African Diaspora Current Institution: University of Chicago Health in Illinois Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Whitehead Institute for Biomedical Research in Cambridge, MA Grant Term: 1/1/2007 through 12/31/2016 Area of Research: Molecular Biology Current Institution: Whitehead Institute for Biomedical Research in Cambridge, MA, Grant Institution: Columbia University in New York City, NY Grant Term: 5/1/1969 through 4/30/1990 Area of Research: Molecular Biology Last Institution: Columbia University in New York City, NY, Grant Institution: Dana-Farber Cancer Institute in Boston Grant Term: 1/1/2023 through 12/31/2027 Area of Research: Molecular and Cellular Oncology Current Institution:Dana-Farber Cancer Institute in Boston, Grant Institution: University of Michigan in Ann Arbor Grant Term: 7/1/2003 through 2/28/2013 Area of Research: Targeting Thrombin Receptor to Treat Advanced Prostate Cancer Current Institution: Johns Hopkins University School of Medicine in Baltimore, MD, Grant Institution: Colorado University in Boulder Grant Term: 7/1/1964 through 3/31/1992 Area of Research: Molecular Biology Last Institution: University of Michigan Health in Ann Arbor, Grant Institution: Washington University, St. Louis Grant Term: 1/1/2011 through 4/21/2011 Area of Research: Functionalizing and Translating the Human Breast Cancer Genome Current Institution: UT MD Anderson Cancer Center in Houston, Grant Institution: Memorial Sloan-Kettering Cancer Center in New York City, NY Grant Term: 7/1/1996 through 6/30/2006 Area of Research: Studies of Neurologic Paraneoplastic Syndromes Current Institution: Memorial Sloan Kettering Cancer Center in New York City, NY, Grant Institution: University of Wisconsin - Madison Grant Term: 7/1/1957 through 6/30/1991 Area of Research: Molecular Biology Last Institution: University of Wisconsin- Madison, Grant Institution: Columbia University in New York City, NY Grant Term: 1/1/1998 through 9/30/2001 Area of Research: Regulating the Functions of the p53 Tumor Suppressor Protein Current Institution: Columbia University in New York City, NY, Grant Institution: University of Colorado, Denver Grant Term: 4/1/1966 through 3/31/1992 Area of Research: Molecular Biology Last Institution: University of Colorado, Denver, Grant Institution: St. Jude Children's Research Hospital in Memphis, TN Grant Term: 7/1/2002 through 6/30/2006 Area of Research: Total Therapy Study XV: Boosting the Cure Rate in Childhood ALL Current Institution: St. Jude Children's Research Hospital in Memphis, TN Childhood Cancer Research Challenges and Opportunities: A Roundtable Discussion, Grant Institution: Baylor University in Waco, TX Grant Term: 7/1/1966 through 3/31/1991 Area of Research: Molecular Biology Last Institution: Baylor University in Waco, TX, Grant Institution: Albert Einstein College of Medicine, Yeshiva University in New York City Grant Term: 10/1/1961 through 3/31/1992 Area of Research: Molecular Biology Last Institution: Albert Einstein College of Medicine, Yeshiva University in New York City, NY, Grant Institution: Fred Hutchinson Cancer Research Center in Seattle, WA Grant Term: 7/1/2017 through 6/30/2022 Area of Research: Establishing Safe and Effective T Cell Antitumor Immunity Current Institution: Fred Hutchinson Cancer Research Center in Seattle, WA, Grant Institution: Massachusetts Institute of Technology in Cambridge, MA Grant Term: 1/1/1993 through 6/30/1996 Area of Research: Cell and Molecular Biology Current Institution: Boston University in Massachusetts, Grant Institution: Memorial Sloan-Kettering Cancer Center in New York City, NY Grant Term: 1/1/1988 through 12/31/1997 Area of Research: Molecular Biology Last Institution: Memorial Sloan-Kettering Cancer Center in New York City, NY, Grant Institution: University of Pittsburgh in Philadelphia Grant Term: 7/1/2008 through 6/30/2018 Area of Research: Head and Neck Cancer as a Model for Bedside-to-Bench Research Current Institution: University of California, San Francisco, Grant Institution: University of California, San Francisco Grant Term: 1/1/2020 through 12/31/2024 Area of Research:Mechanisms of Translation Control in Cancer & its Therapeutic Implications Current Institution:University of California, San Francisco, Grant Institution: The Trustees of the University of Pennsylvania in Philadelphia Grant Term: 1/1/2010 through 12/31/2019 Area of Research: The Genetics and Biology of Squamous Cell Cancers Current Institution: University of Pennsylvania School of Medicine in Philadelphia, Grant Institution: Massachusetts Institute of Technology in Cambridge, MA Grant Term: 1/1/2001 through 6/30/2012 Area of Research: Molecular biology Current Institution: Massachusetts Institute of Technology in Cambridge, MA, Grant Institution:The Pennsylvania State University College of Medicine in Hershey Grant Term: 7/1/2022 through 6/30/2027 Area of Research: Health Services Behavioral Research Current Institution:The Pennsylvania State University College of Medicine in Hershey, Grant Institution: Stanford University in California Grant Term: 1/1/1993 through 6/30/1997 Area of Research: Mechanisms of Resistance to Cancer Agents Last Institution: Stanford University in California, Grant Institution: Sinai Hospital of Baltimore, Inc. in Maryland Grant Term: 1/1/1973 through 12/31/1982 Area of Research: Cell Biology Last Institution: Sinai Hospital of Baltimore, Inc. in Maryland, Grant Institution: Johns Hopkins University in Baltimore, MD Grant Term: 1/1/2012 through 12/31/2021 Area of Research: Role of Hypoxia-Inducible Factor 1 in Breast Cancer Metastasis Current Institution: Johns Hopkins University School of Medicine in Baltimore, MD Nobel Laureates and the American Cancer Society, Grant Institution: The Regents of the University of California, San Francisco Grant Term: 7/1/2010 through 6/30/2020 Area of Research: Molecular Biology Current Institution: University of California San Francisco Podcast: Changing the Shape of Leukemia Research and Clinical Care Childhood Cancer Research Challenges and Opportunities: A Roundtable Discussion, Grant Institution: Princeton University in New Jersey Grant Term: 1/1/1986 through 12/31/1990 Area of Research: Molecular Biology Current Institution: Princeton University in New Jersey, Grant Institution: Boston Children's Hospital in Massachusetts Grant Term: 1/1/2013 through 12/31/2017 Area of Research: Functional and Mechanistic Investigations of Chromatin Regulators Current Institution: Boston Children's Hospital in Massachusetts Expert Predictions: Cancer Care 10 Years from Now, Grant Institution: Memorial Sloan-Kettering Cancer Center In New York City, NY Grant Term: 1/1/2005 through 12/31/2014 Area of Research: RNA Repair Current Institution: Memorial Sloan- Kettering Cancer Center in New York City, NY, Grant Institution: Dartmouth College in Hanover, NH Grant Term: 3/1/1962 through 3/31/1994 Area of Research: Molecular Biology Current Institution: The State University of New York Stony Brook University, Grant Institution: The Regents of the University of California, San Diego Grant Term: 1/1/1987 through 6/30/1991 Area of Research: Cell Biology Last Institution: University of California, San Diego, Grant Institution: University of California, Los Angeles Grant Term: 7/1/2004 through 6/30/2010 Area of Research: Her-2 Alteration in Human Breast Cancer: Delineation of Downstream Molecular Events and Identification of Additional Potential Therapeutic Targets Current Institution: University of California, Los Angeles Seven Breast Cancer Research Success Stories, Grant Institution: Johns Hopkins University in Baltimore, MD Grant Term: 1/1/1990 through 6/30/1998 Area of Research: Molecular Biology Current Institution: IBEJ.